GALAPAGOS NV

GLPGF

Held by 1 specialist biotech fund

Share on X

Fund Holdings

EcoR1 Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

EcoR1 CapitalNEWFeb 17, 2026

Shares: 1,667,119Value: $54.5M

# Signal Note: EcoR1 Capital Initiates $54.5M GLPGF Position EcoR1's entry into Galapagos suggests conviction in the company's pipeline recovery, likely anchored on filgotinib (Jyseleca) commercial traction in rheumatoid arthritis and upcoming data in IBD/ulcerative colitis where oral JAK1 selectivity could differentiate from competitors. The $54.5M stake size indicates confidence in near-term catalysts, potentially including 2024 revenue inflection or Phase 3 data readouts that could justify current valuation pressures from recent pipeline setbacks.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

ETON1 fund MNKD1 fund ORIC1 fund CGON1 fund ANAB1 fund AQST1 fund BBIO1 fund CAMP

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: